Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03544736
Recruitment Status : Active, not recruiting
First Posted : June 4, 2018
Last Update Posted : October 15, 2021
Bristol-Myers Squibb
Information provided by (Responsible Party):
Geir Olav Hjortland, Oslo University Hospital

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 31, 2025
Estimated Study Completion Date : December 31, 2040